BLLNNasdaqServices-Medical Laboratories

BillionToOne, Inc. (BLLN) earnings date, market-implied expected move, and options open interest by expiry

110.24

pre 113.00 +2.31%

Pre-market09:19 ETdelayed

Open109.38Volume360,372Mkt cap$6.0B

Day109.38 – 113.00100%52-wk61.96 – 150.4458%

BLLN

BillionToOne, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

67dJim Cramer Calls BillionToOne (BLLN) a “Pretty Darn Good Company”

News

Next report

Last report

−38.89%

vs ±11.2% implied · ×3.47

shaded = implied · ▲▼ = realized

Aug 5 '26 · confirmed

Implied vs realized

Linked news

1dAMZN · supplierBetterInvesting™ Magazine Update on Amazon.com and UnitedHealth Group

News

Largest filed tie

13F top-10 QoQ

+30.58%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

156 managers

Top fund weight

0.00%

BLLN weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for BillionToOne (BLLN).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 5 '26confirmed±11.2%▼−38.89%×3.47

quarterimplied−40%0+40%realized×

Q2 FY26±11.2%▼−38.89%×3.47

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 30 close

1.34OI · 3 expiries · Oct 30 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1,420+46%Nov 2016d1,061+46%

1,518+1%Dec 1844d0.702,167−1%0.70

4650%Mar 19135d0.231,9860%0.23

ExpiryPutsCallsP/C

Nov 2016d1,420+46%1,061+46%1.34

Dec 1844d1,518+1%2,167−1%0.70

Mar 19135d4650%1,9860%0.23

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

7.36%as filednet margin · revenue +0.98% QoQ · +64.40% YoY

Revenue

$109M+0.98% QoQ

Gross profit

$77M−2.51% QoQ

70.45% margin

Operating income

$6M−69.14% QoQ

5.03% margin

Pre-tax income

$8M−59.38% QoQ

Net income

$8M−55.18% QoQ

7.36% margin

Cost of revenue

$32M+10.41% QoQ

Operating expenses

$72M+16.88% QoQ

SG&A $54M

R&D $17M

Other income

$2M+198.52% QoQ

Tax benefit

$536,000

Revenue$109M+0.98%

Gross profit

$77M−2.51%

70.45% margin

Operating income

$6M−69.14%

5.03% margin

Pre-tax income

$8M−59.38%

Net income

$8M−55.18%

7.36% margin

Cost of revenue

$32M+10.41%

Operating expenses

$72M+16.88%

SG&A $54M

R&D $17M

Other income$2M+198.52%

Tax benefit$536,000

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 09:15 ET

Intraday

Event sensitivity

CPROF ×1.84· ±7.6% vs ±4.1% · 7 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±7.6%3 of 7×1.84

GDPgross domestic product±6.3%6 of 10×1.54

PCEpersonal income & outlays±6.1%7 of 10×1.48

PPIproducer prices±3.1%6 of 10×0.75

CPIconsumer prices±2.9%3 of 10×0.70

NFPjobs report±2.6%4 of 10×0.64

FOMCrate decision±2.4%2 of 7×0.58

Bar = avg |move| to ±8% · tick = ±4.1% avg day · ×base = |move| ÷ ±4.1% · min 6 releases

Earnings history

EPS 0.15 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 5 '26 · confirmed	0.15	—
Q1 FY26	—	0.34	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod